Valuation: WuXi Biologics (Cayman) Inc.

Capitalization 117B 135B 17.24B 14.78B 13.51B 12.86B 23.67B 1,651B 23.88B 161B 62.64B 786B 64.71B 63.33B 2,731B P/E ratio 2026 *
21.4x
P/E ratio 2027 * 17.8x
Enterprise value 106B 123B 15.67B 13.43B 12.27B 11.69B 21.5B 1,500B 21.7B 147B 56.92B 714B 58.8B 57.54B 2,481B EV / Sales 2026 *
4.22x
EV / Sales 2027 * 3.51x
Free-Float
90.02%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: WuXi Biologics (Cayman) Inc.

1 day-3.60%
1 week-1.03%
Current month-1.21%
1 month-7.48%
3 months-18.40%
6 months-5.34%
Current year+3.82%
1 week 32.02
Extreme 32.02
34.7
1 month 32.02
Extreme 32.02
38.34
Current year 30.94
Extreme 30.94
44
1 year 22.95
Extreme 22.95
44
3 years 10.14
Extreme 10.14
52.45
5 years 10.14
Extreme 10.14
148
10 years 8.33
Extreme 8.3333
148
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2016
Director of Finance/CFO 56 23/08/2021
Chief Tech/Sci/R&D Officer 55 31/03/2024
Director TitleAgeSince
Chairman 59 01/02/2014
Director/Board Member 54 01/02/2014
Director/Board Member 42 01/05/2016
Change 5d. change 1-year change 3-years change Capi.($)
-3.60%-1.03%+40.99%-29.12% 17.89B
+1.02%+0.84%+42.05%+87.52% 50.04B
-5.43%-5.50%+72.08%+55.56% 48.62B
-2.01%-15.66%+75.95%+517.30% 25.57B
-0.26%-3.43%-2.66%-12.59% 23.32B
-1.66%-4.83%+32.60%-41.30% 16.2B
-2.75%-7.27%+53.03%+190.95% 14.97B
-3.46%+1.62%-26.29%+954.65% 14.58B
-3.89%-5.40%+38.03% - 13.47B
-0.37%+4.93%+38.29%+166.42% 12.89B
Average -2.24%-1.86%+36.41%+209.93% 23.76B
Weighted average by Cap. -2.15%-2.47%+42.80%+168.47%

Financials

2026 *2027 *
Net sales 25.22B 29.11B 3.72B 3.19B 2.91B 2.77B 5.1B 356B 5.15B 34.77B 13.5B 170B 13.95B 13.65B 589B 29.43B 33.98B 4.34B 3.72B 3.4B 3.24B 5.95B 415B 6.01B 40.58B 15.76B 198B 16.28B 15.93B 687B
Net income 5.49B 6.34B 809M 693M 634M 604M 1.11B 77.48B 1.12B 7.57B 2.94B 36.9B 3.04B 2.97B 128B 6.64B 7.67B 979M 839M 767M 730M 1.34B 93.73B 1.36B 9.15B 3.56B 44.64B 3.67B 3.59B 155B
Net Debt -10.69B -12.34B -1.58B -1.35B -1.23B -1.18B -2.16B -151B -2.18B -14.74B -5.73B -71.87B -5.91B -5.79B -250B -13.68B -15.79B -2.02B -1.73B -1.58B -1.5B -2.77B -193B -2.79B -18.86B -7.33B -91.95B -7.57B -7.41B -319B
Logo WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.
Employees
13,252
Date Price Change Volume
14/05/26 32.64 $ -3.60% 26,986,420
13/05/26 33.86 $ +0.47% 19,669,180
12/05/26 33.70 $ +1.94% 22,628,880
11/05/26 33.06 $ +1.22% 22,588,860
08/05/26 32.66 $ -1.86% 30,075,080
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
28.28CNY
Average target price
40.13CNY
Spread / Average Target
+41.93%

Quarterly revenue - Rate of surprise